GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vilin Bio Med Ltd (NSE:VILINBIO) » Definitions » Notes Receivable

Vilin Bio Med (NSE:VILINBIO) Notes Receivable : ₹0.00 Mil (As of Sep. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Vilin Bio Med Notes Receivable?

Vilin Bio Med's Notes Receivable for the quarter that ended in Sep. 2023 was ₹0.00 Mil.


Vilin Bio Med Notes Receivable Historical Data

The historical data trend for Vilin Bio Med's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vilin Bio Med Notes Receivable Chart

Vilin Bio Med Annual Data
Trend Mar20 Mar21 Mar22
Notes Receivable
- - -

Vilin Bio Med Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Sep23
Notes Receivable - - - - -

Vilin Bio Med Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Vilin Bio Med Notes Receivable Related Terms

Thank you for viewing the detailed overview of Vilin Bio Med's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Vilin Bio Med (NSE:VILINBIO) Business Description

Traded in Other Exchanges
N/A
Address
Opposite Sub Registrar’s Office, Survey No.115/GF/J, Hanumanji Colony, Bowempally, Secunderabad, TG, IND, 500009
Vilin Bio Med Ltd is engaged in the domestic business of manufacturing Pharmaceuticals products. It is manufacturing pharmaceutical formulations such as Oral Liquids, Dry syrups, Sachets, External Preparations, Beta and Non-Beta Lactam tablets, and Capsules & Nutritional Food supplements.

Vilin Bio Med (NSE:VILINBIO) Headlines

No Headlines